TeselaGen Biotechnology develops DNA design and assembly tools for biology.
TeselaGen Biotechnology develops DNA design and assembly tools for biology. It offers a cloud based solution for combinatorial gene design and editing. Its solutions include Graphical Sequence Editor to visualize, edit, and annotate gene and plasmid libraries; Symbolic CAD/CAM to piece together novel constructs using parts from its database; Fabrication Intelligence to generate protocols that are optimized for cost, and verified to assemble quickly and accurately; and Validation to align sequence traces with design variants. Michael Fero, Eduardo Abeliuk, and Nathan Hillson founded TeselaGen on June 1, 2011. It has its headquarters in San Francisco in California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 4, 2014 | Grant | $1.26M | 1 | National Science Foundation | — | Detail |
Jan 1, 2013 | Grant | $150K | 1 | National Science Foundation | — | Detail |
Jun 13, 2012 | Grant | $180K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |